HROW vs TECH · rev $199.6M vs P/E 65, rev $1.22B
Harrow Health Inc (HROW) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Harrow Health Inc (HROW) is a drug manufacturers - specialty & generic company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported HROW revenue for 2024-12-31 was $199.6M. Net income was -$17.5M. Revenue was up 53.3% from 2023-12-31 to 2024-12-31. HROW currently screens at market cap $1.28B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
HROW currently screens at market cap $1.28B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the HROW and TECH stock pages for the full models.
Not investment advice.